以下、Culture Changeのウェブサイトでは、タミフル製造のジレッドサイエンスとその前会長のラムズフェルドとの関係が書いてあります。 http://culturechange.org/cms/index.php?option=com_content&task=view&id=407&Itemid=1 As a former chairman and major stockholder of Gilead Sciences [9], Rummy stands to gain financially from sales of Tamiflu, which, by sheer coincidence, is one of only two [10] anti-viral drugs that H1N1 appears [11] to not tolerate, very odd for a pill genetically designed for avian flu, not swine flu.
1 件のコメント:
ゆみさん、
まさにタイムリーなマシュー君からのメッセージですね。
以下、Culture Changeのウェブサイトでは、タミフル製造のジレッドサイエンスとその前会長のラムズフェルドとの関係が書いてあります。
http://culturechange.org/cms/index.php?option=com_content&task=view&id=407&Itemid=1
As a former chairman and major stockholder of Gilead Sciences [9], Rummy stands to gain financially from sales of Tamiflu, which, by sheer coincidence, is one of only two [10] anti-viral drugs that H1N1 appears [11] to not tolerate, very odd for a pill genetically designed for avian flu, not swine flu.
コメントを投稿